Elevance Health (ELV) Beats Q1 Earnings Estimates
Elevance Health (ELV) came out with quarterly earnings of $10.64 per share, beating the Zacks Consensus Estimate of $10.54 per share. This compares to earnings of $9.46 per share a year ago.
Is a Surprise Coming for Elevance (ELV) This Earnings Season?
Elevance (ELV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Elevance Health (ELV), CD&R to Unveil Primary Care Offering
Elevance Health (ELV) forms an alliance with CD&R to enhance primary care delivery by making collective use of the partners' assets and subsequently, reduce overall costs of care.
Will Elevance (ELV) Beat Q1 Earnings on Carelon Strength?
The first-quarter results of Elevance (ELV) are likely to reflect higher product revenues and Commercial Individual membership growth.
What Analyst Projections for Key Metrics Reveal About Elevance Health (ELV) Q1 Earnings
Besides Wall Street's top -and-bottom-line estimates for Elevance Health (ELV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared dur...
Elevance Health (ELV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Elevance Health (ELV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Elevance Health (ELV) Brand Inks Deal to Better Serve Georgia
Elevance Health's (ELV) brand, Anthem Blue Cross and Blue Shield, collaborates to make the benefits of Piedmont's healthcare network available to its members across specific Georgia regions.
Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2024 Results on April 18, 2024
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release first quarter 2024 financial results on April 18, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review th...
Why Elevance Health (ELV) is Poised to Beat Earnings Estimates Again
Elevance Health (ELV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Wall Street Set to See a Broad-Based Rally in Q2: 5 Picks
It will be prudent to invest in non-technology stocks with a favorable Zacks Rank to gain in the near future. Five such stocks are: WELL, GIS, ELV, RCL, RYAAY.
Kroger Announces Plan to Sell Specialty Pharmacy Business to Elevance Health
Grocery-store chain Kroger (KR) is selling its specialty pharmacy business to U.S. health insurer Elevance Health (ELV).
Kroger to Sell Specialty Pharmacy Business to Elevance Health's CarelonRx
Grocery store operator The Kroger Company plans to sell its specialty pharmacy business to CarelonRx, a subsidiary of Elevance Health. Kroger has entered into a definitive agreement for the sale, t...
Why Elevance (ELV) is a Smart Addition to Your Portfolio Now
Elevance's (ELV) top line is poised to gain from rising product revenues, administrative fees and other revenues.
Elevance Health (ELV) Ascends While Market Falls: Some Facts to Note
The latest trading day saw Elevance Health (ELV) settling at $510.57, representing a +0.21% change from its previous close.
Brokers Suggest Investing in Elevance Health (ELV): Read This Before Placing a Bet
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts oft...
Related Companies